688 related articles for article (PubMed ID: 24646453)
21. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).
Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L
Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135
[TBL] [Abstract][Full Text] [Related]
22. Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles.
Mejías R; Pérez-Yagüe S; Roca AG; Pérez N; Villanueva A; Cañete M; Mañes S; Ruiz-Cabello J; Benito M; Labarta A; Batlle X; Veintemillas-Verdaguer S; Morales MP; Barber DF; Serna CJ
Nanomedicine (Lond); 2010 Apr; 5(3):397-408. PubMed ID: 20394533
[TBL] [Abstract][Full Text] [Related]
23. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
24. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
25. Superparamagnetic Fe3O4 Nanoparticles: Synthesis by Thermal Decomposition of Iron(III) Glucuronate and Application in Magnetic Resonance Imaging.
Patsula V; Kosinová L; Lovrić M; Ferhatovic Hamzić L; Rabyk M; Konefal R; Paruzel A; Šlouf M; Herynek V; Gajović S; Horák D
ACS Appl Mater Interfaces; 2016 Mar; 8(11):7238-47. PubMed ID: 26928653
[TBL] [Abstract][Full Text] [Related]
26. Facile preparation of zwitterion-stabilized superparamagnetic iron oxide nanoparticles (ZSPIONs) as an MR contrast agent for in vivo applications.
Kim D; Chae MK; Joo HJ; Jeong IH; Cho JH; Lee C
Langmuir; 2012 Jun; 28(25):9634-9. PubMed ID: 22607014
[TBL] [Abstract][Full Text] [Related]
27. [Superparamagnetic iron oxide particles: current state and future development].
Taupitz M; Schmitz S; Hamm B
Rofo; 2003 Jun; 175(6):752-65. PubMed ID: 12811686
[TBL] [Abstract][Full Text] [Related]
28. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
[TBL] [Abstract][Full Text] [Related]
29. In vitro evaluation of the L-peptide modified magnetic lipid nanoparticles as targeted magnetic resonance imaging contrast agent for the nasopharyngeal cancer.
Chen YC; Min CN; Wu HC; Lin CT; Hsieh WY
J Biomater Appl; 2013 Nov; 28(4):580-94. PubMed ID: 23174955
[TBL] [Abstract][Full Text] [Related]
30. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging.
Lu J; Ma S; Sun J; Xia C; Liu C; Wang Z; Zhao X; Gao F; Gong Q; Song B; Shuai X; Ai H; Gu Z
Biomaterials; 2009 May; 30(15):2919-28. PubMed ID: 19230966
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI.
Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A
Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737
[TBL] [Abstract][Full Text] [Related]
32. High relaxivities and strong vascular signal enhancement for NaGdF4 nanoparticles designed for dual MR/optical imaging.
Naccache R; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Vander Elst L; Chilian C; Capobianco JA; Fortin MA
Adv Healthc Mater; 2013 Nov; 2(11):1478-88. PubMed ID: 23666643
[TBL] [Abstract][Full Text] [Related]
33. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
[TBL] [Abstract][Full Text] [Related]
34. Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T2 contrast enhancement in magnetic resonance imaging.
Herman DA; Ferguson P; Cheong S; Hermans IF; Ruck BJ; Allan KM; Prabakar S; Spencer JL; Lendrum CD; Tilley RD
Chem Commun (Camb); 2011 Aug; 47(32):9221-3. PubMed ID: 21761066
[TBL] [Abstract][Full Text] [Related]
35. Manipulating the surface coating of ultra-small Gd2O3 nanoparticles for improved T1-weighted MR imaging.
Fang J; Chandrasekharan P; Liu XL; Yang Y; Lv YB; Yang CT; Ding J
Biomaterials; 2014 Feb; 35(5):1636-42. PubMed ID: 24290697
[TBL] [Abstract][Full Text] [Related]
36. Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.
Zeng L; Ren W; Zheng J; Cui P; Wu A
Phys Chem Chem Phys; 2012 Feb; 14(8):2631-6. PubMed ID: 22273844
[TBL] [Abstract][Full Text] [Related]
37. [Preparation and characterization of citric acid-modified superparamagnetic iron oxide nanoparticles].
Wang H; Qin XY; Li ZY; Zheng ZZ; Fan TY
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):340-346. PubMed ID: 29643537
[TBL] [Abstract][Full Text] [Related]
38. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
39. Casein-coated iron oxide nanoparticles for high MRI contrast enhancement and efficient cell targeting.
Huang J; Wang L; Lin R; Wang AY; Yang L; Kuang M; Qian W; Mao H
ACS Appl Mater Interfaces; 2013 Jun; 5(11):4632-9. PubMed ID: 23633522
[TBL] [Abstract][Full Text] [Related]
40. An aqueous method for the controlled manganese (Mn(2+)) substitution in superparamagnetic iron oxide nanoparticles for contrast enhancement in MRI.
Ereath Beeran A; Nazeer SS; Fernandez FB; Muvvala KS; Wunderlich W; Anil S; Vellappally S; Ramachandra Rao MS; John A; Jayasree RS; Varma PR
Phys Chem Chem Phys; 2015 Feb; 17(6):4609-19. PubMed ID: 25586703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
